Michael Mingueneau

Michael Mingueneau

Company: Biogen

Job title: Director, Research


Preclinical & First-In-Human Pharmacology Of BTK Inhibitor BIIB091 11:20 am

A number of BTK inhibitors have been developed over the years, but strikingly not all have demonstrated the same level of efficacy in clinical trials even within the same indication, partly reflecting the complexity of the regulation of this kinase and that not all inhibitors are created equal In this presentation, we will discuss some…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.